Here are the 8-K filings from RF Acquisition Corp II Right (RFAIR) in our archive since June 2025, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
An 8-K covers material events a company has to report between its quarterly reports, so if you follow RFAIR and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full RFAIR filings page.
RF Acquisition Corp II (RFAI) reported results of an extraordinary general meeting held on August 19, 2026 to vote on its proposed business combination with Nanyang Biologics Pte. Ltd. through NYB Holdings Limited (PubCo). Shareholders approved the Business Combination Agreement, the merger of RF Acquisition Corp II into PubCo, the related Nasdaq share issuance, governance provisions, and the NYB Holdings Limited Equity Incentive Plan. An adjournment proposal was also approved but was not needed.
Out of 8,343,765 ordinary shares entitled to vote as of May 20, 2026, 7,206,188 shares (approximately 86.36%) were represented, and each proposal received 6,765,584 votes for and 440,604 against. Holders submitted preliminary requests to redeem 3,956,323 ordinary shares from the Trust Account; these requests may change, and the business combination closing remains subject to satisfaction or waiver of closing conditions.
RF Acquisition Corp II obtained shareholder approval on August 12, 2026 to extend the deadline to complete a business combination beyond August 15, 2026, allowing up to six one‑month extensions through February 15, 2027. Each monthly extension requires depositing $75,000 into the Trust Account in exchange for a non‑interest bearing, unsecured promissory note payable upon a business combination.
The Investment Management Trust Agreement was amended to implement these extensions and to eliminate the company’s prior right to withdraw up to $100,000 of trust interest for liquidation and dissolution expenses. Shareholders also approved corresponding amendments to the company’s charter.
In connection with the meeting, holders of 833,157 ordinary shares redeemed their shares for approximately $9,277,866.57 (about $11.13 per share). After these redemptions, approximately $44,522,115.92 remains in the Trust Account and the company has 3,998,108 ordinary shares outstanding.